Companies: 10,795·Total market cap: $144.5T
OptimizeRx Corporation

OptimizeRx Corporation

OPRXNASDAQHealthcare● Active
$5.05
$-0.06(-1.17%)
Market Cap$94763629
P/E Ratio
52W High$22.25
52W Low$4.57

OptimizeRx Corporation(OPRX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · OPRX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.11B$0.09B$0.07B$0.06B$0.06B
Cost of Revenue$0.04B$0.03B$0.03B$0.02B$0.03B
Gross Profit$0.07B$0.06B$0.04B$0.04B$0.04B
Gross Margin %(computed)63.30%64.45%59.98%62.40%58.14%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.05B$0.06B$0.06B$0.05B$0.03B
Total Operating Expenses$0.06B$0.07B$0.07B$0.05B$0.04B
Operating Income$0.01B($0.01B)($0.03B)($0.01B)$0.00B
Operating Margin %(computed)11.02%-14.88%-36.91%-19.68%0.59%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.00B$0.00B$0.00B
Income Before Tax$0.01B($0.02B)($0.03B)($0.01B)$0.00B
Income Tax Expense$0.00B$0.00B($0.01B)$0.00B$0.00B
Net Income$0.01B($0.02B)($0.02B)($0.01B)$0.00B
Net Margin %(computed)4.69%-21.83%-24.56%-18.32%0.62%
Per Share & EBITDA
EPS (Basic)$0.28$-1.10$-1.03$-0.64$0.02
Wtd Avg Shares0.02B0.02B0.02B0.02B0.02B
EBITDA$0.02B($0.01B)($0.02B)($0.01B)$0.00B
EBITDA Margin %(computed)14.98%-9.66%-29.79%-15.08%3.80%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解OptimizeRx Corporation

关于OptimizeRx Corporation(OPRX)损益表

OptimizeRx Corporation(OPRX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,OPRX实现营收$0.11B,毛利润$0.07B(毛利率63.30%),净利润$0.01B(净利率4.69%)。

常见问题

OPRX · 4 问

OptimizeRx Corporation(OPRX)2025财年营收为$0.11B,同比up18.8%。

OPRX revenueOPRX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08